Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

Recruiting now

Conditions studied: Uterine Neoplasms

In brief

Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm

Key facts

Study ID

NCT03624712

Run by

University Hospital Tuebingen

People needed

580

Starts

2012-01-01

Expected to finish

2027-12-01

Last updated by the study team

2025-01-17

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma)
• If operable: surgical primary therapy: laparoscopic/robot-assisted or open radical gyneco-oncological surgery
• Written consent
• Willingness and ability to participate in all study-specific procedures
• Age ≥ 18 years

You may not qualify if…

• Severe and acute general disease in the last 4 weeks
• Acute or chronic psychiatric disorders
• Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)

Where it is running

• University Hospital Tuebingen, Department of Women's Health — Tübingen, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.